These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 18006818
1. Examination of IGF2 and H19 loss of imprinting in bladder cancer. Byun HM, Wong HL, Birnstein EA, Wolff EM, Liang G, Yang AS. Cancer Res; 2007 Nov 15; 67(22):10753-8. PubMed ID: 18006818 [Abstract] [Full Text] [Related]
7. IGF2 but not H19 shows loss of imprinting in human glioma. Uyeno S, Aoki Y, Nata M, Sagisaka K, Kayama T, Yoshimoto T, Ono T. Cancer Res; 1996 Dec 01; 56(23):5356-9. PubMed ID: 8968084 [Abstract] [Full Text] [Related]
10. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch. Li T, Vu TH, Ulaner GA, Littman E, Ling JQ, Chen HL, Hu JF, Behr B, Giudice L, Hoffman AR. Mol Hum Reprod; 2005 Sep 01; 11(9):631-40. PubMed ID: 16219628 [Abstract] [Full Text] [Related]
11. Loss of imprinting in hepatoblastoma. Rainier S, Dobry CJ, Feinberg AP. Cancer Res; 1995 May 01; 55(9):1836-8. PubMed ID: 7728748 [Abstract] [Full Text] [Related]
12. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. Li X, Adam G, Cui H, Sandstedt B, Ohlsson R, Ekström TJ. Oncogene; 1995 Jul 20; 11(2):221-9. PubMed ID: 7624139 [Abstract] [Full Text] [Related]
13. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors. Nonomura N, Miki T, Nishimura K, Kanno N, Kojima Y, Okuyama A. J Urol; 1997 May 20; 157(5):1977-9. PubMed ID: 9112575 [Abstract] [Full Text] [Related]
14. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP. Nat Genet; 1994 Jul 20; 7(3):433-9. PubMed ID: 7920665 [Abstract] [Full Text] [Related]
16. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR. Xu W, Fan H, He X, Zhang J, Xie W. J Exp Clin Cancer Res; 2006 Dec 20; 25(4):543-7. PubMed ID: 17310846 [Abstract] [Full Text] [Related]
17. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer. Zuo QS, Yan R, Feng DX, Zhao R, Chen C, Jiang YM, Cruz-Correa M, Casson AG, Kang XD, Han F, Chen T. Mol Carcinog; 2011 May 20; 50(5):390-6. PubMed ID: 21268128 [Abstract] [Full Text] [Related]
18. Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19. Constância M, Dean W, Lopes S, Moore T, Kelsey G, Reik W. Nat Genet; 2000 Oct 20; 26(2):203-6. PubMed ID: 11017078 [Abstract] [Full Text] [Related]
19. Loss of IGF2 imprinting: mechanisms and consequences. Ohlsson R. Novartis Found Symp; 2004 Oct 20; 262():108-21; discussion 121-4, 265-8. PubMed ID: 15562825 [Abstract] [Full Text] [Related]
20. Decreased expression of p57(KIP2)mRNA in human bladder cancer. Oya M, Schulz WA. Br J Cancer; 2000 Sep 20; 83(5):626-31. PubMed ID: 10944603 [Abstract] [Full Text] [Related] Page: [Next] [New Search]